Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ITUS ITUS (ITUS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About ITUS Stock (NASDAQ:ITUS) 30 days 90 days 365 days Advanced Chart Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Get ITUS alerts:Sign Up Key Stats Today's Range$4.61▼$4.7650-Day Range N/A52-Week Range$1.83▼$6.43Volume69,859 shsAverage Volume134,373 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAnixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the body's immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immune-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.Read More… Receive ITUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ITUS and its competitors with MarketBeat's FREE daily newsletter. Email Address ITUS Stock News HeadlinesGMFS Itus Virtus Underground Toy Drive!December 4, 2024 | msn.comUS recession coming in 2025? How will it affect the stock markets? Here's how to navigate itNovember 7, 2024 | msn.com70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.December 26, 2024 | WealthPress (Ad)6 arrested in Titus County following investigation into child trafficking, prostitutionNovember 2, 2024 | msn.comSherlock wins FR Americas Race 1 at COTANovember 2, 2024 | msn.comUS Election 2024: ‘Smart, tough, trusted’: Joe Biden’s high praise for Kamala Harris, says Trump lacks these qualitiesOctober 29, 2024 | msn.comTop events on October 15: PM Modi to inaugurate ITU's telecom meet, PVR Inox Q2 results, Jaishankar in Pakistan and moreOctober 15, 2024 | msn.comPM Modi to inaugurate 8th ITU's telecom standard meet, India Mobile Congress in Delhi todayOctober 15, 2024 | msn.comSee More Headlines ITUS Stock Analysis - Frequently Asked Questions How were ITUS's earnings last quarter? ITUS Co. (NASDAQ:ITUS) released its quarterly earnings data on Friday, March, 9th. The business services provider reported ($0.11) earnings per share (EPS) for the quarter. What other stocks do shareholders of ITUS own? Based on aggregate information from My MarketBeat watchlists, some other companies that ITUS investors own include Synergy Pharmaceuticals (SGYP), Galectin Therapeutics (GALT), Catalyst Pharmaceuticals (CPRX), Halozyme Therapeutics (HALO), Progenics Pharmaceuticals (PGNX), Palatin Technologies (PTN) and Anixa Biosciences (ANIX). Company Calendar Last Earnings3/09/2018Today12/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Patent Owners & Lessors Sub-IndustryN/A Current SymbolNASDAQ:ITUS CUSIPN/A CIK715446 Webwww.ituscorp.com Phone(408) 708-9808FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report This page (NASDAQ:ITUS) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ITUS Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ITUS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
